Supplementary Tables S1- S6 from Distinct Chemopreventive Effects of Aspirin in Diffuse and Intestinal-Type Gastric Cancer

Supplementary Table 1. Characteristics of gastric cancer patients. Supplementary Table 2. Gastric cancer location, TNM staging in propensity score-matched patients with aspirin. Supplementary Table 3. Associations between the duration of aspirin use and outcomes in patients with aspirin (N = 2082). Supplementary Table 4. Gastric cancer location, TNM staging in propensity score-matched patients with NSAIDs. Supplementary Table 5. Baseline characteristics of unmatched and propensity score-matched patients in PPI-user and non-user groups. Supplementary Table 6. Gastric cancer, intestinal metaplasia, and neutrophil infiltration in propensity score-matched patients with PPI.